Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Screening applications to test cellular fitness in transwell® models after nanoparticle treatment

: Christ, Bastian; Fey, Christina; Cubukova, Alevtina; Walles, Heike; Dembski, Sofia; Metzger, Marco


Gilbert, D.:
Cell Viability Assays. Methods and Protocols
New York/NY: Springer Science+Business Media, 2017 (Methods in molecular biology 1601)
ISBN: 978-1-4939-6959-3 (Print)
ISBN: 978-1-4939-6960-9 (Online)
Aufsatz in Buch
Fraunhofer ISC ()
Fraunhofer IGB ()
Zellen; Nanopartikel; Zytotoxizität; Impedanz-Spektroskopie

Nanoparticles (NPs) in biotechnology hold great promise for revolutionizing medical treatments and therapies. In order to bring NPs into clinical application there is a number of preclinical in vitro and in vivo tests, which have to be applied before. The initial in vitro evaluation includes a detailed physicochemical characterization as well as biocompatibility tests, among others. For determination of biocompatibility at the cellular level, the correct choice of the in vitro assay as well as NP pretreatment is absolutely essential. There are a variety of assay technologies available that use standard plate readers to measure metabolic markers to estimate the number of viable cells in culture. Each cell viability assay has its own set of advantages and disadvantages. Regardless of the assay method chosen, the major factors critical for reproducibility and success include: (1) choosing the right assay after comparing optical NP properties with the read-out method of the assay, (2) verifying colloidal stability of NPs in cell culture media, (3) preparing a sterile and stable NP dispersion in cell culture media used in the assay, (4) using a tightly controlled and consistent cell model allowing appropriate characterization of NPs. This chapter will briefly summarize these different critical points, which can occur during biocompatibility screening applications of NPs.